ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.61 Billion SEK | 107.42% |
| 2022 | 777.85 Million SEK | 40.36% |
| 2021 | 554.18 Million SEK | 186.59% |
| 2020 | 193.37 Million SEK | -1.37% |
| 2019 | 196.05 Million SEK | 4.63% |
| 2018 | 187.38 Million SEK | 10.93% |
| 2017 | 168.91 Million SEK | 29.28% |
| 2016 | 130.66 Million SEK | 45.63% |
| 2015 | 89.72 Million SEK | -16.52% |
| 2014 | 107.48 Million SEK | 153.53% |
| 2013 | 42.39 Million SEK | 38.95% |
| 2012 | 30.51 Million SEK | 1059.23% |
| 2011 | 2.63 Million SEK | -25.14% |
| 2010 | 3.51 Million SEK | 0.0% |
| 2008 | 1.23 Million SEK | -14.76% |
| 2007 | 1.45 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.62 Billion SEK | 0.73% |
| 2024 Q3 | 1.73 Billion SEK | -5.16% |
| 2024 Q2 | 1.82 Billion SEK | 12.42% |
| 2023 Q2 | 1.13 Billion SEK | 44.51% |
| 2023 Q1 | 783.2 Million SEK | 0.69% |
| 2023 Q3 | 1.12 Billion SEK | -1.02% |
| 2023 FY | 1.61 Billion SEK | 107.42% |
| 2023 Q4 | 1.61 Billion SEK | 44.03% |
| 2022 Q4 | 777.85 Million SEK | 38.99% |
| 2022 FY | 777.85 Million SEK | 40.36% |
| 2022 Q1 | 550.51 Million SEK | -0.66% |
| 2022 Q2 | 555.72 Million SEK | 0.95% |
| 2022 Q3 | 559.66 Million SEK | 0.71% |
| 2021 Q3 | 322.57 Million SEK | 2.07% |
| 2021 Q4 | 554.18 Million SEK | 71.8% |
| 2021 Q1 | 179.61 Million SEK | -7.12% |
| 2021 Q2 | 316.04 Million SEK | 75.96% |
| 2021 FY | 554.18 Million SEK | 186.59% |
| 2020 Q2 | 194.68 Million SEK | 2.82% |
| 2020 Q4 | 193.37 Million SEK | -1.86% |
| 2020 Q3 | 197.03 Million SEK | 1.21% |
| 2020 Q1 | 189.35 Million SEK | -3.42% |
| 2020 FY | 193.37 Million SEK | -1.37% |
| 2019 FY | 196.05 Million SEK | 4.63% |
| 2019 Q4 | 196.05 Million SEK | -2.7% |
| 2019 Q2 | 199.07 Million SEK | -2.8% |
| 2019 Q1 | 204.81 Million SEK | 9.3% |
| 2019 Q3 | 201.48 Million SEK | 1.21% |
| 2018 FY | 187.38 Million SEK | 10.93% |
| 2018 Q4 | 187.38 Million SEK | -0.8% |
| 2018 Q3 | 188.89 Million SEK | 13.32% |
| 2018 Q2 | 166.69 Million SEK | -1.4% |
| 2018 Q1 | 169.07 Million SEK | 0.09% |
| 2017 Q4 | 168.91 Million SEK | 15.67% |
| 2017 Q3 | 146.02 Million SEK | 6.96% |
| 2017 Q2 | 136.52 Million SEK | 9.83% |
| 2017 Q1 | 124.3 Million SEK | -4.87% |
| 2017 FY | 168.91 Million SEK | 29.28% |
| 2016 Q4 | 130.66 Million SEK | 10.56% |
| 2016 Q3 | 118.18 Million SEK | 14.3% |
| 2016 Q2 | 103.39 Million SEK | -0.98% |
| 2016 Q1 | 104.41 Million SEK | 16.38% |
| 2016 FY | 130.66 Million SEK | 45.63% |
| 2015 Q1 | 113.27 Million SEK | 5.39% |
| 2015 Q2 | 101.2 Million SEK | -10.65% |
| 2015 Q4 | 89.72 Million SEK | -6.49% |
| 2015 Q3 | 95.95 Million SEK | -5.19% |
| 2015 FY | 89.72 Million SEK | -16.52% |
| 2014 FY | 107.48 Million SEK | 153.53% |
| 2014 Q4 | 107.48 Million SEK | 122.16% |
| 2014 Q3 | 48.38 Million SEK | -0.62% |
| 2014 Q2 | 48.68 Million SEK | -2.03% |
| 2014 Q1 | 49.69 Million SEK | 17.21% |
| 2013 Q3 | 42.72 Million SEK | 282.65% |
| 2013 Q4 | 42.39 Million SEK | -0.78% |
| 2013 FY | 42.39 Million SEK | 38.95% |
| 2013 Q1 | 20 Million SEK | -34.45% |
| 2013 Q2 | 11.16 Million SEK | -44.17% |
| 2012 Q3 | 25.76 Million SEK | 3.64% |
| 2012 FY | 30.51 Million SEK | 1059.23% |
| 2012 Q1 | 14.43 Million SEK | 448.25% |
| 2012 Q4 | 30.51 Million SEK | 18.43% |
| 2012 Q2 | 24.85 Million SEK | 72.26% |
| 2011 Q4 | 2.63 Million SEK | -16.81% |
| 2011 FY | 2.63 Million SEK | -25.14% |
| 2011 Q2 | 3.65 Million SEK | 12.22% |
| 2011 Q1 | 3.25 Million SEK | -7.34% |
| 2011 Q3 | 3.16 Million SEK | -13.46% |
| 2010 Q2 | - SEK | 0.0% |
| 2010 FY | 3.51 Million SEK | 0.0% |
| 2010 Q1 | - SEK | 0.0% |
| 2010 Q4 | 3.51 Million SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2009 Q1 | 1.23 Million SEK | 0.0% |
| 2009 Q2 | - SEK | -100.0% |
| 2008 FY | 1.23 Million SEK | -14.76% |
| 2008 Q4 | - SEK | 0.0% |
| 2008 Q1 | 1.45 Million SEK | 0.0% |
| 2007 FY | 1.45 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 0.0% |
| Arcoma AB | 3.87 Million SEK | -41557.63% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | -592.152% |
| BICO Group AB (publ) | 1.85 Billion SEK | 12.935% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | -871.343% |
| CellaVision AB (publ) | 64.7 Million SEK | -2393.547% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -355274.449% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -89533.333% |
| Duearity AB (publ) | 10.58 Million SEK | -15146.645% |
| Dignitana AB (publ) | 19.1 Million SEK | -8345.352% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -30926.923% |
| Getinge AB (publ) | 8.07 Billion SEK | 80.022% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -19457.253% |
| Iconovo AB (publ) | 7.72 Million SEK | -20785.68% |
| Integrum AB (publ) | 6.42 Million SEK | -25014.485% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -783012.647% |
| Mentice AB (publ) | 9.55 Million SEK | -16781.867% |
| OssDsign AB (publ) | 3.15 Million SEK | -51119.048% |
| Paxman AB (publ) | 13.57 Million SEK | -11789.462% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | -7682.548% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -23636.943% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | -4975.5% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -37368.648% |
| Senzime AB (publ) | 11.46 Million SEK | -13968.713% |
| SpectraCure AB (publ) | 6.71 Million SEK | -23919.652% |
| Stille AB | 62.94 Million SEK | -2463.312% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 22.767% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | -5032.169% |